Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
1.855
-0.135 (-6.78%)
Mar 31, 2025, 1:15 PM EDT - Market open
PRME's stock price has decreased by -73.39% in the past year and price targets may not have had time to catch up.
Prime Medicine Analyst Ratings
Total Analysts
9
Consensus Rating
Strong Buy
Price Target
$13.25
Upside
+614.29%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Chardan Capital | Chardan Capital | Strong Buy Maintains $15 → $16 | Strong Buy | Maintains | $15 → $16 | +762.53% | Mar 20, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +439.08% | Mar 19, 2025 |
Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $10 | Buy | Reiterates | $10 | +439.08% | Mar 4, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +439.08% | Mar 3, 2025 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +708.63% | Mar 3, 2025 |
JMP Securities | JMP Securities | Buy Initiates $10 | Buy | Initiates | $10 | +439.08% | Dec 10, 2024 |
Guggenheim | Guggenheim | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +870.35% | Dec 3, 2024 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $17 → $15 | Strong Buy | Maintains | $17 → $15 | +708.63% | Nov 13, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +439.08% | Nov 13, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +439.08% | Oct 25, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +439.08% | Oct 2, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +439.08% | Aug 9, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +439.08% | May 20, 2024 |
Citigroup | Citigroup | Hold → Strong Buy Upgrades $10 | Hold → Strong Buy | Upgrades | $10 | +439.08% | May 16, 2024 |
JP Morgan | JP Morgan | Buy Maintains $16 → $15 | Buy | Maintains | $16 → $15 | +708.63% | May 13, 2024 |
Jefferies | Jefferies | Strong Buy Initiates $23 → $15 | Strong Buy | Initiates | $23 → $15 | +708.63% | May 7, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.